About Bioverativ

At Bioverativ, we are dedicated to transforming the lives of people with hemophilia, cold agglutinin disease and other rare blood disorders. As an independent biotechnology company spun out of Biogen’s hemophilia business, we bring a strong legacy of innovation, world-class science, and commitment to the rare blood disorders community. We are united by a singular purpose: to create progress where patients need it most.